ประกวดราคาซื้อยา จำนวน ๒ รายการ

This announcement is for a bidding process to procure Manidipine Hydrochloride 20 mg tablets for oral administration. The objective is to acquire high-quality medication suitable for patient treatment. The project encompasses the specification of general characteristics such as dosage form, ingredients, packaging, and labeling, along with technical properties related to quality analysis results in accordance with established standards.

Bidders are required to submit documents pertaining to drug registration, Good Manufacturing Practice (GMP) standards, drug quality analysis results, stability study results, and other relevant documents to demonstrate the quality of the medication. Additionally, bidders must provide drug samples for government inspection and guarantee the quality of the delivered medication, ensuring a shelf life of at least 12 months from the delivery date, and agree to replace any medication that is near expiration or deteriorates prematurely.

The evaluation criteria will be based on the proposed price (40%) and the quality and beneficial properties for the government (60%). This includes consideration of clinical study reports, registration in the Green Book or US Orange Book, drug analysis results from accredited laboratories, and other properties such as tablet divisibility and clear labeling on blister packs.